AVAH NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Aveanna Healthcare Holdings Inc · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 9.39 USD
-0.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 21.7% above the Trend Line and sits at 85.9% of its 52-week range. The latest completed week returned -0.6%, after a 3.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 49/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 55 out of 100
Latest Close 9.39 USD 31 Jul 2026
1W Return -0.6% latest completed week
4W Return 3.2% short-term follow-through
12W Return 39.3% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.6% Latest completed week; four-week move 3.2%. Indicator stack 38/76 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 49/100 conviction; expected move 18.8%. News sentiment 57/100 73 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 21.7% above the Trend Line and sits at 85.9% of its 52-week range. The latest completed week returned -0.6%, after a 3.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5212-week average 0.20

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.52Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.2% over four weeks, 39.3% over 12 weeks, and 151.1% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W-0.6%
4W3.2%
12W39.3%
26W11.8%
52W151.1%
Active trend streak2 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.31Latest activity-pressure read.
Pressure change34.6%Four-week change in activity pressure.
Leadership6.58Latest relative-leadership reading.
RS change70.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength93/100Blend of value, momentum, and quality. Underlying universe rank 8; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality75/100Profitability and accounting quality. Underlying universe rank 26; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth79/100Revenue and earnings growth. Underlying universe rank 22; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework80/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
7.9x
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
11.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
32.7%
Gross profit retained from each unit of revenue.
Operating margin
10.9%
Operating profit retained from revenue.
Free-cash-flow margin
6.0%
Free cash flow generated from revenue.
Return on invested capital
13.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
20.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
250.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

AVAH shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.16, expected move of 18.8%, and Sharemaestro trend signal active.

Conviction49/100
Expected move18.8%
Put/call volume0.16
Pressure82
Speculation10
Volatility96
Trend agreement13
Open options detail
Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 73 relevant articles.

25 positive · 47 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move18.8%Nearest-chain priced movement where available.
52-week drawdown-9.0%Distance below the 52-week high.
13-week volatility6.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+14.5%Week of 15 May.
Worst week-7.4%Week of 20 Feb.
Latest week-0.6%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses9
Sharp losses5
Recent vol6.3%13-week weekly-return volatility.
Base vol10.5%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew8.2% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis45/100

Latest 12-week confirmation: trend 2/12, activity pressure 10/12, relative leadership 6/12.

Activity pressure 0.52; 2 reversal markers Factors83/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74; Small Cap Core rank 67 SVQF80/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 147.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options38/100

AVAH shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.16, expected move of 18.8%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 18.8% Sentiment57/100

Weighted news tone is neutral across 73 relevant articles.

Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences Insiders0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20269.39 USD-0.6%7.71 USD5.09 USD1.316.588.1MOn
24 Jul 20269.45 USD-2.5%7.67 USD5.04 USD1.318.9710.1MOn
17 Jul 20269.69 USD-0.1%7.64 USD4.99 USD1.3411.1010.5MOff
10 Jul 20269.70 USD6.6%7.62 USD4.94 USD1.207.7212.9MOff
3 Jul 20269.10 USD5.1%7.60 USD4.89 USD0.973.867.3MOff
26 Jun 20268.66 USD11.2%7.61 USD4.84 USD0.820.3818.5MOff
19 Jun 20267.79 USD9.9%7.63 USD4.79 USD0.56-13.357.4MOff
12 Jun 20267.09 USD6.1%7.66 USD4.75 USD0.49-18.838.2MOff
5 Jun 20266.68 USD-6.8%7.71 USD4.72 USD0.56-21.7011.1MOff
29 May 20267.17 USD-2.2%7.78 USD4.69 USD0.25-19.875.4MOff
22 May 20267.33 USD-5.1%7.84 USD4.65 USD-0.17-15.797.9MOff
15 May 20267.72 USD14.5%7.91 USD4.61 USD-0.63-10.2713.8MOff
8 May 20266.74 USD2.0%7.98 USD4.57 USD-1.11-21.996.4MOff
1 May 20266.61 USD0.9%8.04 USD4.53 USD-1.29-19.505.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.